These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 35052787
21. Production of lentiviral vectors for transducing cells from the central nervous system. Li M, Husic N, Lin Y, Snider BJ. J Vis Exp; 2012 May 24; (63):e4031. PubMed ID: 22664962 [Abstract] [Full Text] [Related]
22. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Yu X, Zhan X, D'Costa J, Tanavde VM, Ye Z, Peng T, Malehorn MT, Yang X, Civin CI, Cheng L. Mol Ther; 2003 Jun 24; 7(6):827-38. PubMed ID: 12788657 [Abstract] [Full Text] [Related]
23. Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins. Lee CL, Dang J, Joo KI, Wang P. Virus Res; 2011 Sep 24; 160(1-2):340-50. PubMed ID: 21802459 [Abstract] [Full Text] [Related]
25. Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of transduction enhancers. Ingrao D, Majdoul S, Seye AK, Galy A, Fenard D. Hum Gene Ther Methods; 2014 Feb 24; 25(1):48-56. PubMed ID: 24152219 [Abstract] [Full Text] [Related]
26. Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies. Daniel-Moreno A, Lamsfus-Calle A, Wilber A, Chambers CB, Johnston I, Antony JS, Epting T, Handgretinger R, Mezger M. Blood Cells Mol Dis; 2020 Sep 24; 84():102456. PubMed ID: 32498026 [Abstract] [Full Text] [Related]
27. Application of lentiviral vectors for development of production cell lines and safety testing of lentiviral-derived cells or products. Plewa C. PDA J Pharm Sci Technol; 2010 Sep 24; 64(5):386-91. PubMed ID: 21502042 [Abstract] [Full Text] [Related]
28. Advances in lentiviral vectors: a patent review. Picanco-Castro V, de Sousa Russo-Carbolante EM, Tadeu Covas D. Recent Pat DNA Gene Seq; 2012 Aug 24; 6(2):82-90. PubMed ID: 22670608 [Abstract] [Full Text] [Related]
29. Lentiviral vectors in clinical trials: Current status. D'Costa J, Mansfield SG, Humeau LM. Curr Opin Mol Ther; 2009 Oct 24; 11(5):554-64. PubMed ID: 19806504 [Abstract] [Full Text] [Related]
30. Lentiviral vectors: basic to translational. Sakuma T, Barry MA, Ikeda Y. Biochem J; 2012 May 01; 443(3):603-18. PubMed ID: 22507128 [Abstract] [Full Text] [Related]
31. Making lentiviral vectors more powerful and universal. Ye Z, Cheng L. Discov Med; 2003 Oct 01; 3(18):48-9. PubMed ID: 20704865 [Abstract] [Full Text] [Related]
32. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line. Nordin F, Hamid ZA, Chan L, Farzaneh F, Hamid MK. Methods Mol Biol; 2016 Oct 01; 1448():159-73. PubMed ID: 27317180 [Abstract] [Full Text] [Related]
34. Construction of stable producer cells to make high-titer lentiviral vectors for dendritic cell-based vaccination. Lee CL, Chou M, Dai B, Xiao L, Wang P. Biotechnol Bioeng; 2012 Jun 01; 109(6):1551-60. PubMed ID: 22179950 [Abstract] [Full Text] [Related]